Skip to main content
. 2021 Aug 13;22:689. doi: 10.1186/s12891-021-04578-x

Table 1.

Demographics of the Study Groups

Demographics Group A (n = 23) Group B (n = 39) p Value
Age (y)a 64.13 ± 9.10 64.56 ± 10.88 .873
Sexb . 424
 Male 10 (43.48%) 13 (33.33%)
 Female 13 (56.52%) 26 (66.67%)
BMI (kg/m2) a 26.16 ± 2.83 25.55 ± 3.61 .493
Involved jointb <0.01
 Hip 7 (30.43%) 34 (87.18%)
 Knee 16 (69.57%) 5 (12.82%)
Serum inflammatory and fibrinolytic markers
 CRP (mg/L) 45.71 ± 54.50 3.57 ± 4.62 <.05
 ESR (mm/h) 57.59 ± 27.97 14.59 ± 10.33 <.001
 D-dimer (mg/L) 1.72 ± 1.22 1.06 ± 1.23 <.001
 K (min) 1.26 ± 0.77 1.56 ± 0.41 <.001
 Angle(°) 72.56 ± 7.38 67.80 ± 6.13 <.001
 MA (mm) 71.23 ± 5.62 62.83 ± 4.03 <.001
 A30(mm) 70.85 ± 5.79 62.36 ± 4.16 <.001
 TPI(/sec) 126.28 ± 54.46 60.30 ± 26.24 <.001

BMI body mass index, SD standard deviation, CRP C-reactive protein, ESR erythrocyte sedimentation rate, K clotting time, Angle α-angle, MA maximum amplitude, A30 amplitude at 30 min, TPI thrombodynamic potential index

a The values are expressed as the mean ± SD

b The values are expressed as the numbers of patients, with the percentage in parentheses